Could Pitt genetic procedure allow people with type 1 diabetes to produce their own insulin?

Alan D. Attie, a professor of biochemistry at the University of Wisconsin Madison, described the study as “an exciting development in the diabetes field” with the big question of whether the new beta cells will “stimulate the immune attack of type 1 diabetes” and “whether or not there are ways to protect the new beta cells from immune attack.”